Mar 12 2025 |
Federal Circuit Affirms ImmunoGen Patent Obviousness |
ArentFox Schiff LLP |
Mar 12 2025 |
Compounded GLP-1 Drugs: Texas Judge Denies PI Motion and Request for Stay of FDA’s Declaration that Tirzepatide Shortage is Resolved; Plaintiff OFA Appeals |
Foley & Lardner LLP |
Mar 12 2025 |
GLP-1 Receptor Agonists and Patent Strategy: Securing Patent Protection for New Use of Old Drugs |
Foley & Lardner LLP |
Mar 12 2025 |
Georgia Legislature Considering Substantial Overhaul to Medical Marijuana, Hemp Laws |
Bradley Arant Boult Cummings LLP |
Mar 11 2025 |
Reminder: FDA Does, In Fact, Review DOF |
Sheppard, Mullin, Richter & Hampton LLP |
Mar 11 2025 |
Federal Circuit Affirms District Court’s Obviousness Judgment on ImmunoGen Patent Application |
Polsinelli PC |
Mar 11 2025 |
Leveraging USPTO Delays To Maximize Patent Term |
Foley & Lardner LLP |
Mar 11 2025 |
SuperValu Wins False Claims Act Case with a “No Harm, No Foul” Jury Verdict |
Sheppard, Mullin, Richter & Hampton LLP |
Mar 11 2025 |
Federal Appeals Court Rules Against Doctor Seeking to Use Mushrooms to Aide Terminal Patients: How We Learned to Question the Rationale of the Controlled Substances Act |
Bradley Arant Boult Cummings LLP |
Mar 11 2025 |
EU Advocate General Recommends Overturning Decision Annulling Harmonized Classification and Labeling of Titanium Dioxide |
Bergeson & Campbell, P.C. |
Mar 10 2025 |
Healthcare Preview for the Week of: March 10, 2025 [Podcast] |
McDermott Will & Schulte LLP |
Mar 10 2025 |
Appellate Court Paves Way for Launch of Alabama Medical Cannabis Program: Watch What Happens Now |
Bradley Arant Boult Cummings LLP |
Mar 9 2025 |
FDA Issues FSVP-Related Warning Letters |
Keller and Heckman LLP |
Mar 7 2025 |
EPA Will Extend Deadline for Reporting Health and Safety Data for 16 Chemicals |
Bergeson & Campbell, P.C. |
Mar 6 2025 |
First Circuit Adopts But-For Causation Standard for Kickback-Premised False Claims Act Actions |
K&L Gates LLP |
Mar 5 2025 |
HHS Reverses Its Longstanding Policy and Limits Public Participation in Rulemaking |
Epstein Becker & Green, P.C. |
Mar 5 2025 |
First Circuit Joins Other Circuits in Adopting Stricter Causation Standard in FCA Cases Based on Anti-Kickback Statute |
Bradley Arant Boult Cummings LLP |
Mar 5 2025 |
Federal Circuit Refuses to Rehear Case Involving Orange Book Listing of Device Patents |
Polsinelli PC |
Mar 5 2025 |
This Week in 340B: February 25 – March 3, 2025 |
McDermott Will & Schulte LLP |
Mar 5 2025 |
How Alcohol Exporters Can Use FDII and IC-DISC to Maximize Tax Savings |
McDermott Will & Schulte LLP |
Mar 5 2025 |
New State Legislative Efforts to Regulate Color Additives in Food |
Keller and Heckman LLP |
Mar 5 2025 |
Meat Industry Pushes Back on Cultivated Meat Bans |
Keller and Heckman LLP |
Mar 5 2025 |
Raw Milk: State Legislative Updates and Challenges |
Keller and Heckman LLP |
Mar 5 2025 |
Cultivated Meat: Legislative Challenges from Georgia and South Dakota |
Keller and Heckman LLP |
Mar 4 2025 |
Attention North Carolina Retailers: Time to Renew Your ABC Permits! |
Ward and Smith, P.A. |
Mar 4 2025 |
Pest Practices: EPA Uses FIFRA EPA to Adopt Additional Operational and Workplace Controls on Ethylene Oxide |
K&L Gates LLP |
Mar 4 2025 |
No Funny Business: The Supreme Court Should Get Sirois |
Bradley Arant Boult Cummings LLP |
Mar 3 2025 |
Alabama Legislature Weighs Substantial Cannabis Reforms: Let’s All Take a Deep Breath |
Bradley Arant Boult Cummings LLP |
Mar 2 2025 |
Connecticut Bill Addresses “Shrinkflation” |
Keller and Heckman LLP |
Feb 28 2025 |
APHIS Will Begin Accepting Petitions for Nonregulated Status on March 3, 2025 |
Bergeson & Campbell, P.C. |
Feb 28 2025 |
McDermott+ Check-Up: February 28, 2025 |
McDermott Will & Schulte LLP |
Feb 27 2025 |
Florida Appellate Court Rules Hookah Products are Taxable OTP |
Jones Walker LLP |
Feb 27 2025 |
A Regulatory Haze of Uncertainty Continues as the Clock Ticks Toward Phase One of FDA’s LDT Final Rule |
Epstein Becker & Green, P.C. |
Feb 27 2025 |
Florida Court Rules That the Florida Constitution Required a Public Employer to Accommodate Off-Duty Medical Marijuana Use |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
Feb 27 2025 |
TSCA Developments — A Conversation with Richard E. Engler, Ph.D. [Podcast] |
Bergeson & Campbell, P.C. |